RegisterLogin

Cucurbitacin B

CAT: 0804-HY-N0416-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-N0416-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Cucurbitacin B belongs to a class of highly oxidized tetracyclic triterpenoids and is oral active. Cucurbitacin B inhibits tumor cell growth, migration and invasion and cycle arrest, but induces cell apoptosis. Cucurbitacin B has potent anti-inflammatory, antioxidant, antiviral, hypoglycemic, hepatoprotective, neuroprotective activity[1][2][3][4][5].
CAS Number
[6199-67-3]
UNSPSC
12352211
Hazard Statement
H300
Target
Apoptosis; Autophagy; COX; Endogenous Metabolite; HIF/HIF Prolyl-Hydroxylase; Integrin; ROS Kinase
Type
Natural Products
Related Pathways
Apoptosis; Autophagy; Cytoskeleton; Immunology/Inflammation; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease; Others
Assay Protocol
https://www.medchemexpress.com/Cucurbitacin-B.html
Purity
99.92
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL
Smiles
O[C@H](C1)[C@@]([C@@](C)(O)C(/C=C/C(OC(C)=O)(C)C)=O)([H])[C@](C2)(C)[C@]1(C)[C@]3([H])CC=C4C(C)(C)C([C@@H](O)C[C@@]4([H])[C@]3(C)C2=O)=O
Molecular Formula
C32H46O8
Molecular Weight
558.70
Precautions
H300
References & Citations
[1]Shang Y, et al. Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN. Eur Rev Med Pharmacol Sci. 2014;18 (21) :3297-303.|[2]Zhang M, et al. Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells. Mol Med Rep. 2014 Dec;10 (6) :2905-11.|[3]Gupta P, et al. Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression. Oncotarget. 2014 Apr 15;5 (7) :1812-28.|[4]Guo J, et al. Cucurbitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner. PLoS One. 2014 Feb 4;9 (2) :e88140.|[5]Dai S, , et al. Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics. Pharmacol Res. 2023;187:106587. |[6]Klungsaeng, et al. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells. Am J Chin Med. 2020;48 (6) :1475-1489. |[7]Lin Y, et al. Cucurbitacin B Exerts Antiaging Effects in Yeast by Regulating Autophagy and Oxidative Stress. Oxid Med Cell Longev. 2019;2019:4517091.|[8]Aljohani OS. Phytochemical evaluation of Cucumis prophetarum: protective effects against carrageenan-induced prostatitis in rats. Drug Chem Toxicol. 2022;45 (4) :1461-1469. |[9]Liu Z, Kumar M, Kabra A. Cucurbitacin B exerts neuroprotection in a murine Alzheimer's disease model by modulating oxidative stress, inflammation, and neurotransmitter levels. Front Biosci (Landmark Ed) . 2022;27 (2) :71.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported

Related Products

CatalogName
HY-N4175-01Cucurbitacin A
HY-N0417-01Cucurbitacin E
HY-N1405-01Cucurbitacin I
HY-N9968Cucurbitacin C
HY-N0725Cucurbitacin S
HY-N12461Cucurbitacin F
HY-N1986-01Cucurbitacin D
HY-N1987-01Cucurbitacin IIb
HY-N1988-01Cucurbitacin IIa
HY-N8137-01Cucurbitacin Q1

Alternative Products

CatalogName
RM-C212001-01Cucurbitacin A
N2201-20Cucurbitacin Ⅱa
M29247-01Cucurbitacin Q1
M21911-01Cucurbitacin S
M17554-01Cucurbitacin B
M18669-01Cucurbitacin IIb
AB0583Cucurbitacin C
300124Cucurbitacin E
445161-01Cucurbitacin D
371322Cucurbitacin A discontinued

Popular Products